Related Experiment Video

Updated: Jun 1, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

Revascularization of left main coronary artery disease

Ming-Sum Lee1, David P Faxon

  • 1Cardiovascular Division, Brigham and Women's Hospital, Boston, MA. mslee@partners.org

Cardiology in Review
|June 8, 2011
PubMed

Insights

Left main stenosis, a severe coronary artery disease, shows comparable survival with percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). The SYNTAX trial highlights similar outcomes but notes a higher stroke rate with CABG.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Left main coronary artery stenosis is linked to high mortality.
  • Early studies favored coronary artery bypass grafting (CABG) over medical therapy for survival benefits.
  • Percutaneous coronary intervention (PCI) was initially limited due to poor outcomes, reserved for inoperable patients or 'protected' left main disease.

Purpose of the Study:

  • To evaluate the comparative effectiveness of PCI and CABG for left main stenosis.
  • To assess survival rates and clinical outcomes in patients treated with PCI versus CABG.
  • To analyze the impact of drug-eluting stents on revascularization strategies for left main disease.

Main Methods:

  • Review of historical studies comparing CABG and medical therapy.
  • Analysis of outcomes from the SYNTAX trial comparing PCI with drug-eluting stents versus CABG.
  • Utilizing the SYNTAX scoring system for risk stratification in left main stenosis patients.

Main Results:

  • Drug-eluting stents have led to comparable survival rates between PCI and CABG.
  • PCI is associated with a higher rate of repeat revascularization compared to CABG.
  • The SYNTAX trial showed similar rates of death, myocardial infarction, and stroke between PCI and CABG, with a lower stroke rate in the PCI group.

Conclusions:

  • PCI with drug-eluting stents offers a viable alternative to CABG for selected left main stenosis patients.
  • Risk stratification using the SYNTAX score aids in selecting the optimal revascularization strategy (PCI or CABG).
  • While PCI survival is comparable, careful consideration of repeat revascularization rates is necessary.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...